Taros Chemicals GmbH & Co. KG

www.tarosdiscovery.com

Taros, a privately owned chemistry CRO and custom synthesis provider has been serving pharmaceutical, biotech and chemical companies since 1999.

About us

Taros, a privately owned chemistry CRO and custom synthesis provider has been serving pharmaceutical, biotech and chemical companies since 1999.

Within our drug discovery division, we provide holistic medicinal chemistry services to clients on their way to the next clinical candidate. Having a strong scientific track record on many biomolecular targets in all main therapeutic areas we add considerable value to collaborations from target validation and hit identification to lead optimization.

Our chemical services include discovery chemistry, custom synthesis, process chemistry, medicinal chemistry, computational chemistry and molecular modeling, as well as the design of compound libraries and the production of screening compounds.

Taros was leading the chemistry activities of the European Lead Factory (ELF), a EUR 196 m drug discovery platform and is also the lead of its recent continuation (ESCulab) funded with EUR 36.5 m.

Address
Taros Chemicals GmbH & Co. KG
Emil-Figge-Str. 76a
44227 Dortmund
Germany

Phone: +49 231 22619811
Fax: +49 231 22619819
Internet: www.tarosdiscovery.com

Contact person

Youri Mesmoudi
Executive Vice President
Phone: +49 231 226198-11
Dr. Thorsten Genski
Senior Medicinal Chemist
Phone: +49 231 226198-11


Products and services

Taros’ core expertise in Drug Discovery encompasses:
• Medicinal chemistry from hit validation to candidate selection
• Expertise on many biomolecular targets across all main therapeutic areas
• Dedicated group for computational chemistry and molecular modelling
• Partners for outsourcing disease biology, HTS, ADME, DMPK, X-ray crystallography
• Strong track record in compound library design and production by parallel synthesis; heading chemistry consortium within the European Lead Factory (ELF)
• Excellence in custom synthesis, process development, and scale-up to pilot plant

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We only use functionally necessary cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection